To learn more about the MMRF, please visit our official website: http://www.themmrf.org
Favorite Pages
Social RSS
twitt | blog |
 Kathy Giusti Twitter Updates
| Report | |
|---|---|
|
KathyGiusti: At faster cures mtg in new york-fascinating discussion with mike milken and his team-innovation the key
13 Oct 2009, 8:37 am |
|
|
KathyGiusti: So sad to hear that Kenny Perry's mom passed away of myeloma. She fought an amazing battle.
3 Oct 2009, 3:10 pm |
|
|
KathyGiusti: Paint the Town Pink so nice today. Great job Sarah Burke.
3 Oct 2009, 10:17 am |
|
|
KathyGiusti: Headed to dc to meet with fda
30 Sep 2009, 3:44 am |
|
|
KathyGiusti: Just launched our new website at www.themmrf.org
24 Sep 2009, 12:51 pm |
Causes
Multiple Myeloma Research Foundation doesn't have any causes.
Basic Info
Detailed Info
- Website:
- http://www.multiplemyeloma.org
- Company Overview:
- The Multiple Myeloma Research Foundation (MMRF) was founded in 1998 by identical twin sisters Kathy Giusti and Karen Andrews shortly following Kathy’s diagnosis with multiple myeloma, an incurable blood cancer.
- Mission:
- The mission of the MMRF is to urgently and aggressively fund research that will lead to the development of new treatments for multiple myeloma.
- Products:
- As the world's number-one private funder of multiple myeloma research, the MMRF has raised more than $130 million to fund 120 laboratories worldwide. The payback on our investment has been significant:
Four new treatments —Thalomid, Velcade, Revlimid and Doxil— approved in the past five years alone when it usually takes nearly 10 years to bring a single treatment to market. These breakthrough treatments are extending the lives of myeloma patients worldwide and are now being explored in a range of other cancers, including ovarian cancer, breast cancer, prostate cancer, leukemia, and Non-Hodgkin's lymphoma
The MMRF has supported 40 new compounds and approaches in clinical trials and pre- clinical studies and has facilitated 20 clinical trials of novel and combination treatments facilitated by our sister organization, the Multiple Myeloma Research Consortium (MMRC).
The MMRF is one of the most effective and efficient organizations of its kind, as evidenced by our exceptional accreditations. Nearly 93% of every dollar of revenue raised was directed toward myeloma research and related educational programs.
The MMRF's approach, with a focus on speed, innovation, and results, is widely recognized across the medical and scientific communities, as well as by several prominent publications, as an optimal model to accelerate medical research and drug development across various cancers and diseases.